Article Details
Retrieved on: 2018-02-05 15:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Valeant Pharmaceuticals Intl Inc logo Zacks Investment Research lowered shares of Valeant Pharmaceuticals Intl (NYSE:VRX) (TSE:VRX) from a hold rating to a strong sell rating in a research note released on Saturday, January 13th. According to Zacks, “After a tumultuous period, Valeant started a ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here